These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6774532)

  • 1. [Modified variant of simultaneous discontinuation of psychotropic drugs (given in combination with diuretics) as a method of abrupt termination therapy for protracted episodes of schizophrenia].
    Tsygankov BD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):754-9. PubMed ID: 6774532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Various methods of overcoming resistance to therapy in childhood and adolescent schizophrenia].
    Antropov IuF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(10):1522-6. PubMed ID: 6118983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
    Gamburg AL; Aranovich AG; Kotel'kevich IuN; Omorokov BM; Rasniuk VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The place of pyrogen therapy in the modern treatment of schizophrenia patients].
    Malin DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):81-5. PubMed ID: 1332338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The place of insulin coma therapy among the current methods of treating patients with paroxysmal schizophrenia].
    Kalinin VV; Rudik VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(5):745-9. PubMed ID: 3739489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outpatient arrest of recidives and exacerbations in schizophrenia].
    Neduva AA; Avrutskiĭ GIa; Kozyrev VN; Afanas'eva VK; Niss AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(1):117-22. PubMed ID: 629135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhanced sensitivity to psychotropic preparations and its relation to organic brain insufficiency].
    Niss AI; Trubkovich MIa; Seid-Rzaev SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):114-9. PubMed ID: 3414263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regression analysis of clinical data for purposes of predicting the efficacy of psychopharmacotherapy of episodes of schizophrenia].
    Zaĭtsev SG; Kalinin VV; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):91-7. PubMed ID: 3953201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of psychopharmacotherapy on the course of forced insulin-coma treatment of patients with paranoid schizophrenia].
    Skatkin AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(12):1836-9. PubMed ID: 3447400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of psychotropic drugs in the insidious deconstruction of the Kraepelinian dichotomy.
    Vinar O
    Psychiatr Danub; 2007 Dec; 19(4):354-8. PubMed ID: 18000488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia.
    Ito C; Kubota Y; Sato M
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S35-40. PubMed ID: 10560896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of nonpsychotic states of decompensation among oligophrenic patients including deviant forms of behavior].
    Golodets RG; Sukhotina NK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):413-7. PubMed ID: 3577536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principles for long-term pharmacological treatment of schizophrenic patients].
    Perris C
    Lakartidningen; 1977 Apr; 74(15):1495-7. PubMed ID: 846272
    [No Abstract]   [Full Text] [Related]  

  • 19. [Associated psychotropic drugs in deficit schizophrenia].
    Beaufils B
    Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of controlled augmentation trials in schizophrenia.
    Stern RG; Schmeidler J; Davidson M
    Biol Psychiatry; 1997 Jul; 42(2):138-43. PubMed ID: 9209731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.